Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease:a Prospective Multi-center Cohort Study

NCT02982135 is registered in ClinicalTrials.gov with liuxingju as lead sponsor.

NCT NCT02982135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02982135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease:a Prospective Multi-center Cohort Study
Lead sponsor
liuxingju
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2018
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

moyamoya disease